Detection of sites of infection in mice using 99mTc-labeled PN2S-PEG conjugated to UBI and 99mTc-UBI: a comparative biodistribution study

Nuclear Medicine and Biology

Volumn 36, Issue 1, 2009, Pages 57-64

  Meléndez Alafort, Laura ^a   Nadali, Anna ^a   Pasut, Gianfranco ^a   Zangoni, Elena ^a   De Caro, Raffaele ^a   Cariolato, Luca ^a   Giron, Maria Cecilia ^a   Castagliuolo, Ignazio ^a   Veronese, Francesco M ^a   Mazzi, Ulderico ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Infection detection; Labeled peptides; PEG; PN2S; Technetium 99m; Ubiquicidin

Indexed keywords

CYSTEINE; LIGAND; MACROGOL; POLY(ETHYLENEGLYCOL) N [N (3 DIPHENYLPHOSPHINOPROPIONYL)GLYCYL] S TRITYLCYSTEINE UBIQUICIDIN TC 99M; POLYPEPTIDE ANTIBIOTIC AGENT; TECHNETIUM 99M; UBIQUICIDIN; UBIQUICIDIN TC 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD; BONE; CONTROLLED STUDY; DILUTION; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; DRUG PURITY; DRUG STABILITY; DRUG STRUCTURE; DRUG UPTAKE; EX VIVO STUDY; GALLBLADDER; HEART; HISTOPATHOLOGY; IN VIVO STUDY; INFECTION; INTESTINE; ISOTOPE LABELING; KIDNEY; KIDNEY CLEARANCE; LIVER; LUNG; MOUSE; MUSCLE; NONHUMAN; PLASMA CLEARANCE; QUALITY CONTROL; RETICULOENDOTHELIAL SYSTEM; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCINTIGRAPHY; SPLEEN; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; STOMACH; THYROID GLAND; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CYSTEINE; ORGANOTECHNETIUM COMPOUNDS; POLYETHYLENE GLYCOLS; RIBOSOMAL PROTEINS; STAINING AND LABELING; STAPHYLOCOCCAL INFECTIONS; TISSUE DISTRIBUTION;

EID: 58749115781     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2008.10.011     Document Type: Article

References (22)

1. Buscombe J.R. The future of infection imaging. Q J Nucl Med Mol Imag 50 (2006) 99-103
2. Nibbering P.H., Welling M.M., Paulusma-Annema A., Brouwer C., Lupetti A., and Pauwels E.K.J. Tc-99m-labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J Nucl Med 45 (2004) 321-326
3. Thakur M.L. Radiolabeled peptides - now and the future. Nucl Med Comm 16 (1995) 724-732
4. Welling M.M., Mongera S., Lupetti A., Balter H.S., Bonetto V., Mazzi U., et al. Radiochemical and biological characteristics of Tc-99m-UBI 29-41 for imaging of bacterial infections. Nucl Med Biol 29 (2002) 413-422
5. Melendez-Alafort L., Ramirez F.D., Ferro-Flores G., de Murphy C.A., Pedraza-Lopez M., and Hnatowich D.J. Lys and Arg in UBI: A specific site for a stable Tc-99m complex?. Nucl Med Biol 30 (2003) 605-615
6. Ferro-Flores G., Ramirez F.D., Melendez-Alafort L., de Murphy C.A., and Pedraza-Lopez M. Molecular recognition and stability of Tc-99m-UBI 29-41 based on experimental and semiempirical results. Appl Radiat Isot 61 (2004) 1261-1268
7. Saeed M., Iqbal J., Khan M.A., Irfanullah J., Jehangir M., Khan B., et al. Tc-99m-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphylococcus aureus infection. J Nucl Med 45 (2004) 849-856
8. Ferro-Flores G., de Murphy C.A., Pedraza-Lopez M., Melendez-Alafort L., Zhang Y.M., Rusckowski M., et al. In vitro and in vivo assessment of Tc-99m-UBI specificity for bacteria. Nucl Med Biol 30 (2003) 597-603
9. Melendez-Alafort L., Rodriguez-Cortes J., Ferro-Flores G., De Murphy C.A., Herrera-Rodriguez R., Mitsoura E., et al. Biokinetics of Tc-99m-UBI 29-41 in humans. Nucl Med Biol 31 (2004) 373-379
10. Ferro-Flores G., de Murphy C.A., Palomares-Rodriguez P., Melendez-Alafort L., and Pedraza-Lopez M. Kit for instant Tc-99m labeling of the antimicrobial peptide ubiquicidin 29-41. J Radioanal Nucl Chem 266 (2005) 307-311
11. Welling M.M., Korsak A., Gorska B., Oliver P., Mikolajczak R., Balter H.S., et al. Kit with technetium-99m labelled antimicrobial peptide UBI 29-41 for specific infection detection. J Label Compd Radiopharm 48 (2005) 683-691
12. 99mTc-UBI 29-41 scintigraphy for specific detection of experimental Staphylococcus aureus prosthetic joint infections. Eur J Nucl Med Mol Imaging 34 (2007) 1302-1309
13. Akhtar M.S., Qaisar A., Irfanullah J., Iqbal J., Khan B., Jehangir M., et al. Antimicrobial peptide Tc-99m-ubiquicidin 29-41 as human infection-imaging agent: Clinical trial. J Nucl Med 46 (2005) 567-573
14. Gemmel F., Dumarey N., and Palestro C.J. Radionuclide imaging of spinal infections. Eur J Nucl Med Mol Imaging 33 (2006) 1226-1237
15. Welling M.M., Visentin R., Feitsma H.I.J., Lupetti A., Pauwels E.K.J., and Nibbering P.H. Infection detection in mice using Tc-99m-labeled HYNIC and N2S2 conjugated to the antimicrobial peptide UBI 29-41. Nucl Med Biol 31 (2004) 503-509
16. Pasut G., Caboi F., Schrepfer R., Tonon G., Schiavon O., and Veronese F.M. New active poly(ethylene glycol) derivative for amino coupling. React Funct Polym 67 (2007) 529-539
17. Pasut G., and Veronese F.M. Polymer-drug conjugation, recent achievements and general strategies. Prog Polym Sci 32 (2007) 933-961
18. Veronese F.M., and Pasut G. PEGylation, successful approach to drug delivery. Drug Discov Today 10 (2005) 1451-1458
19. Visentin R., Pasut G., Veronese F.M., and Mazzi U. Highly efficient technetium-99m labeling procedure based on the conjugation of N-[N-(3-diphenylphosphinopropionyl)-glycyl]cysteine ligand with poly(ethylene glycol). Bioconjugate Chem 15 (2004) 1046-1054
20. 99mTc-MIBI scintimammography using a dedicated nuclear mammograph. J Nucl Med 40 (1999) 46-51
21. Snyder S.L., and Sobocinski B.Z. An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines. Anal Biochem 64 (1975) 284-288
22. Caliceti P., and Veronese F.M. Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates. Adv Drug Deliv Rev 55 (2003) 1261-1277